BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38734897)

  • 1. BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism.
    Yang Q; Zhu X; Huang P; Li C; Han L; Han Y; Gan R; Xin B; Tu Y; Zhou S; Yuan T; Hao J; Li C; Zhang L; Shi L; Guo C
    Mol Ther; 2024 May; ():. PubMed ID: 38734897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bckdk-Mediated Branch Chain Amino Acid Metabolism Reprogramming Contributes to Muscle Atrophy during Cancer Cachexia.
    Chen L; Zhang H; Chi M; Wang Y; Zhu X; Han L; Xin B; Gan R; Tu Y; Sun X; Lu J; Li J; Huang J; Zhang J; Han Y; Guo C; Yang Q
    Mol Nutr Food Res; 2023 Dec; ():e2300577. PubMed ID: 38150655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency.
    Ohl L; Kuhs A; Pluck R; Durham E; Noji M; Philip ND; Arany Z; Ahrens-Nicklas RC
    Mol Genet Metab Rep; 2024 Jun; 39():101091. PubMed ID: 38770403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of BCAA catabolism enhances Rab1A-mTORC1 signaling activity and promotes tumor proliferation in NSCLC.
    Xue M; Xiao J; Jiang W; Wang Y; Zuo D; An H; Ren L
    Transl Oncol; 2023 Aug; 34():101696. PubMed ID: 37216755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer.
    Xue P; Zeng F; Duan Q; Xiao J; Liu L; Yuan P; Fan L; Sun H; Malyarenko OS; Lu H; Xiu R; Liu S; Shao C; Zhang J; Yan W; Wang Z; Zheng J; Zhu F
    EBioMedicine; 2017 Jun; 20():50-60. PubMed ID: 28501528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCKDK alters the metabolism of non-small cell lung cancer.
    Wang Y; Xiao J; Jiang W; Zuo D; Wang X; Jin Y; Qiao L; An H; Yang L; Dumoulin DW; Dempke WCM; Best SA; Ren L
    Transl Lung Cancer Res; 2021 Dec; 10(12):4459-4476. PubMed ID: 35070754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency.
    Ohl L; Kuhs A; Pluck R; Durham E; Noji M; Philip ND; Arany Z; Ahrens-Nicklas RC
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
    Tian Q; Yuan P; Quan C; Li M; Xiao J; Zhang L; Lu H; Ma T; Zou L; Wang F; Xue P; Ni X; Wang W; Liu L; Wang Z; Zhu F; Duan Q
    Oncogene; 2020 May; 39(20):3980-3996. PubMed ID: 32238881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment.
    Yang Q; Hao J; Chi M; Wang Y; Li J; Huang J; Zhang J; Zhang M; Lu J; Zhou S; Yuan T; Shen Z; Zheng S; Guo C
    Mol Ther; 2022 Mar; 30(3):1188-1200. PubMed ID: 35007759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation.
    Li C; Yang Q; Zhang L
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2290458. PubMed ID: 38059302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism.
    Yang Q; Hao J; Chi M; Wang Y; Xin B; Huang J; Lu J; Li J; Sun X; Li C; Huo Y; Zhang J; Han Y; Guo C
    Oncoimmunology; 2022; 11(1):2055703. PubMed ID: 35355679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment.
    Bravo-Alonso I; Oyarzabal A; Sánchez-Aragó M; Rejas MT; Merinero B; García-Cazorla A; Artuch R; Ugarte M; Rodríguez-Pombo P
    Data Brief; 2016 Jun; 7():755-9. PubMed ID: 27054191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched-chain amino acid catabolic defect in vascular smooth muscle cells drives thoracic aortic dissection via mTOR hyperactivation.
    Yu L; Huang T; Zhao J; Zhou Z; Cao Z; Chi Y; Meng S; Huang Y; Xu Y; Xia L; Jiang H; Yin Z; Wang H
    Free Radic Biol Med; 2024 Jan; 210():25-41. PubMed ID: 37956909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy.
    Boemer F; Josse C; Luis G; Di Valentin E; Thiry J; Cello C; Caberg JH; Dadoumont C; Harvengt J; Lumaka A; Bours V; Debray FG
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched-chain amino acid metabolism, insulin sensitivity and liver fat response to exercise training in sedentary dysglycaemic and normoglycaemic men.
    Lee S; Gulseth HL; Langleite TM; Norheim F; Olsen T; Refsum H; Jensen J; Birkeland KI; Drevon CA
    Diabetologia; 2021 Feb; 64(2):410-423. PubMed ID: 33123769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients.
    García-Cazorla A; Oyarzabal A; Fort J; Robles C; Castejón E; Ruiz-Sala P; Bodoy S; Merinero B; Lopez-Sala A; Dopazo J; Nunes V; Ugarte M; Artuch R; Palacín M; Rodríguez-Pombo P; Alcaide P; Navarrete R; Sanz P; Font-Llitjós M; Vilaseca MA; Ormaizabal A; Pristoupilova A; Agulló SB
    Hum Mutat; 2014 Apr; 35(4):470-7. PubMed ID: 24449431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting BCKDK in triple negative breast cancer suppresses protein translation, impairs mitochondrial function, and potentiates doxorubicin cytotoxicity.
    Biswas D; Slade L; Duffley L; Mueller N; Dao KT; Mercer A; Pakkiriswami S; El Hiani Y; Kienesberger PC; Pulinilkunnil T
    Cell Death Discov; 2021 Sep; 7(1):241. PubMed ID: 34526485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn screening.
    Tangeraas T; Constante JR; Backe PH; Oyarzábal A; Neugebauer J; Weinhold N; Boemer F; Debray FG; Ozturk-Hism B; Evren G; Tuba EF; Ummuhan O; Footitt E; Davison J; Martinez C; Bueno C; Machado I; Rodríguez-Pombo P; Al-Sannaa N; De Los Santos M; López JM; Ozturkmen-Akay H; Karaca M; Tekin M; Pajares S; Ormazabal A; Stoway SD; Artuch R; Dixon M; Mørkrid L; García-Cazorla A
    Brain; 2023 Jul; 146(7):3003-3013. PubMed ID: 36729635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Branched-Chain Amino Acids and Branched-Chain α-Keto Acid Dehydrogenase Kinase in Metabolic Disorders.
    Du C; Liu WJ; Yang J; Zhao SS; Liu HX
    Front Nutr; 2022; 9():932670. PubMed ID: 35923208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of branched-chain amino acid interactions in 10 to 20 kg nursery pigs using a central composite design.
    Humphrey DC; Haydon K; Greiner LL
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37527486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.